Express Scripts Hold...
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
Express Scripts Holding Co. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 25,600 (as per Q1 2017)no data available
Sector Health Care Plans, HealthcareHealth Care Plans, Healthcareno data available
Ticker ESRXno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 175058667482
datesClosing price (adj.)
13.10.201757.14
11.10.201757.71
04.10.201763.98
27.09.201762.96
20.09.201761.82
13.09.201763.24
06.09.201762.69
30.08.201761.53
23.08.201760.93
16.08.201762.00
09.08.201761.20
02.08.201761.98
26.07.201763.47
19.07.201762.05
12.07.201762.12
05.07.201763.68
27.06.201764.62
20.06.201763.42
13.06.201762.63
06.06.201760.25
30.05.201759.60
23.05.201760.15
16.05.201760.16
09.05.201762.08
02.05.201761.70
25.04.201760.01
18.04.201766.09
11.04.201766.77
04.04.201765.89
28.03.201764.84
21.03.201763.84
14.03.201766.84
07.03.201767.39
28.02.201770.65
21.02.201771.37
14.02.201769.63
07.02.201767.74
31.01.201768.88
24.01.201771.40
17.01.201773.16
10.01.201772.50
03.01.201769.40
27.12.201669.60
19.12.201669.24
12.12.201672.10
05.12.201676.71
28.11.201676.75
21.11.201676.10
14.11.201676.45
07.11.201670.38
31.10.201667.40
24.10.201669.80
17.10.201669.22
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 57.14n/a
Market Capitalisation
in million USD
 33,914n/a
Enterprise Value
in million USD
 46,413n/a
Common Shares Outstanding
as per Mar 31, 2017
 593,527,000n/a
Preferred Shares Outstanding
as per Mar 31, 2017
 n/a
Average Basic Shares Outstanding
TTM
 615,900,000n/a
Average Diluted Shares Outstanding
TTM
 620,250,000n/a
Index Membership
n/a
Business Summary
Express Scripts Holding Co is a pharmacy benefit manager in the United States. It offers healthcare management and administration services such as managed care organizations, health insurers, workers\' compensation plans and government health programs.
no data available
Key Financials & Ratios (all figures TTM as per Dec 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 100,288n/a
Gross Profit 8,621n/a
Operating Income 5,088n/a
EBITDA 7,242n/a
Net Profit 3,404n/a
Balance Sheet
Cash and Cash Equivalents 3,077n/a
Receivables 7,062n/a
Total Current Assets 12,363n/a
PP&E 1,274n/a
Total Assets 51,745n/a
Accounts Payable 3,876n/a
Current Debt 722n/a
Total Current Liabilities 16,428n/a
Long-Term Debt 14,846n/a
Total Liabilities 35,501n/a
Total Equity 16,244n/a
Cash Flow
Depreciation & Amortisation 2,155n/a
Change in Working Capital -236n/a
Operating Cash Flow 4,919n/a
Net Change in PP&E and Intangibles -330n/a
Investing Cash Flow -352n/a
Dividends Paid 0n/a
Financing Cash Flow -4,678n/a
Total Change in Cash -109n/a
Free Cash Flow 5,676n/a
Profitability Ratios
Gross Margin 8.6%n/a
Operating Margin 5.1%n/a
Net Profit Margin 3.4%n/a
Return on Equity 21.1%n/a
Return on Assets 6.6%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 6.41n/a
EV/Sales 0.46n/a
Book to Market Value 0.48n/a
Other Ratios
Current Ratio 75.3%n/a
Liabilities to Equity Ratio 218.6%n/a
Debt to Assets Ratio 30.1%n/a
Profit & Loss StatementP&L data quality: 51% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
44,973
46,128
93,714
104,099
100,887
101,752
100,288
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-42,015
-42,918
-86,402
-95,966
-92,962
-93,350
-91,667
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
2,958
3,210
7,312
8,132
7,925
8,402
8,621
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-887
-896
-4,518
-4,581
-4,323
-4,063
-3,533
Selling, General & Administrative
-887
-896
-4,518
-4,581
-4,323
-4,063
-3,533
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
2,071
2,314
2,794
3,552
3,602
4,339
5,088
Non-Operating Income (Loss)
-162
-287
-594
-521
-536
-476
-661
Interest Expense, net
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
15
0
0
0
0
Other Non-Operating Income (Loss)
-162
-287
-608
-521
-536
-476
-661
Pretax Income (Loss), Adjusted
1,909
2,027
2,200
3,030
3,066
3,864
4,427
Abnormal Gains (Losses)
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
1,909
2,027
2,200
3,030
3,066
3,864
4,427
Income Tax (Expense) Benefit, net
-704
-749
-838
-1,104
-1,031
-1,364
-1,000
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
1,205
1,279
1,362
1,926
2,035
2,500
3,428
Net Extraordinary Gains (Losses)
-23
0
-32
-54
0
0
0
Discontinued Operations
-23
0
-32
-54
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
1,181
1,279
1,330
1,873
2,035
2,500
3,428
Minority Interest
0
-3
-17
-28
-27
-23
-23
Net Income
1,181
1,276
1,313
1,845
2,008
2,476
3,404
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
1,181
1,276
1,313
1,845
2,008
2,476
3,404
Remarks
restated on Feb 19, 2013 n/a
calculated values,
restated on Feb 20, 2014 n/a
calculated values,
restated on Feb 23, 2015 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
5,620
2,793
1,991
1,833
3,186
3,077
Cash & Cash Equivalents
n/a
5,620
2,793
1,991
1,833
3,186
3,077
Short Term Investments
n/a
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
1,916
5,426
4,023
5,980
6,721
7,062
Accounts Receivable, Net
n/a
1,916
5,426
4,023
5,980
6,721
7,062
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
374
1,652
1,871
2,113
2,023
1,959
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
148
886
606
643
129
265
Prepaid Expenses
n/a
84
194
97
252
129
265
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
46
401
455
391
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
271
31
0
0
0
Miscellaneous Short Term Assets
n/a
18
20
23
0
0
0
Total Current Assets
n/a
8,058
10,757
8,491
10,568
12,060
12,363
Property, Plant & Equipment, Net
n/a
416
1,632
1,659
1,584
1,291
1,274
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
7,133
45,722
43,398
41,596
39,893
38,108
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
5,486
29,320
29,305
29,281
29,277
29,278
Other Intangible Assets
n/a
1,621
16,038
14,016
12,201
10,470
8,637
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
26
364
77
114
146
193
Total Noncurrent Assets
n/a
7,549
47,354
45,057
43,180
41,184
39,382
Total Assets
n/a
15,607
58,111
53,548
53,748
53,243
51,745
Liabilities and owners' equity
Payables & Accruals
n/a
4,458 4458200000
11,972 11971800000
11,650 11650000000
14,462 14461600000
15,509 15508900000
15,706 15705800000
Accounts Payable
n/a
928 928100000
2,899 2898900000
2,900 2900000000
3,137 3137300000
3,452 3451800000
3,876 3875700000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
3,530 3530100000
9,073 9072900000
8,750 8750000000
11,324 11324300000
12,057 12057100000
11,830 11830100000
Short Term Debt
n/a
1,000 999900000
935 934900000
1,584 1584000000
2,551 2551000000
1,646 1646400000
722 722300000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
151 150700000
1 1300000
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
151 150700000
1 1300000
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
5,458 5458100000
13,057 13057400000
13,235 13235300000
17,013 17012600000
17,155 17155300000
16,428 16428100000
Long Term Debt
n/a
7,076 7076400000
14,980 14980100000
12,363 12363000000
10,966 10966400000
13,946 13946300000
14,846 14846000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
597 597200000
6,678 6678000000
6,105 6105100000
5,705 5705300000
4,761 4761200000
4,227 4227000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
547 546500000
5,937 5936500000
5,441 5440600000
4,923 4923200000
4,070 4069800000
3,603 3603300000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
49 48600000
0 100000
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
51 50700000
693 692900000
664 664400000
782 782100000
691 691400000
624 623700000
Total Noncurrent Liabilities
n/a
7,674 7673600000
21,658 21658100000
18,468 18468100000
16,672 16671700000
18,708 18707500000
19,073 19073000000
Total Liabilities
n/a
13,132 13131700000
34,716 34715500000
31,703 31703400000
33,684 33684300000
35,863 35862800000
35,501 35501100000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
2,445 2445100000
21,298 21297900000
21,818 21818200000
22,680 22679900000
22,213 22213200000
23,242 23242200000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-6,634 -6634000000
0 0
-3,905 -3905300000
-8,548 -8548200000
-13,223 -13223200000
-18,795 -18795100000
Retained Earnings
n/a
6,646 6645600000
2,068 2068200000
3,913 3912800000
5,920 5920400000
8,397 8396800000
11,801 11801200000
Other Equity
n/a
17 17000000
19 18900000
12 11700000
2 2100000
-14 -14000000
-12 -12300000
Equity Before Minority Interest
n/a
2,474 2473700000
23,385 23385000000
21,837 21837400000
20,054 20054200000
17,373 17372800000
16,236 16236000000
Minority Interest
n/a
2 1600000
11 10700000
7 7400000
10 9800000
8 7700000
8 7800000
Total Equity
n/a
2,475 2475300000
23,396 23395700000
21,845 21844800000
20,064 20064000000
17,381 17380500000
16,244 16243800000
Total Liabilities & Equity
n/a
15,607 15607000000
58,111 58111200000
53,548 53548200000
53,748 53748300000
53,243 53243300000
51,745 51744900000
Remarks restated on n/a restated on Feb 19, 2013 n/a restated on Feb 20, 2014 n/a restated on Feb 23, 2015 n/a restated on Feb 16, 2016 n/a restated on Feb 14, 2017 n/a restated on Apr 24, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
1,205
1,279
1,362
1,926
2,035
2,500
3,428
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
245
253
1,871
2,447
2,243
2,359
2,155
Non-Cash Items
180
284
92
-380
-328
-391
-427
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
476
378
1,426
775
599
381
-236
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
12
0
31
-11
0
0
0
Cash from Operating Activities
2,117
2,193
4,782
4,758
4,549
4,848
4,919
Change in Fixed Assets & Intangibles
-120
-144
-160
-423
-437
-296
-330
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
3
0
-10,222
357
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
-28
21
-4
-4
25
27
-22
Net Cash From Discontinued Operations (investing)
-1
0
-5
-2
0
0
0
Cash from Investing Activities
-146
-124
-10,392
-72
-412
-269
-352
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-1,340
5,580
1,990
-1,932
-344
2,109
54
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-1,241
-2,484
326
-3,589
-3,983
-5,317
-4,660
Increase in Capital Stock
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
58
-67
534
26
37
-9
-72
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
-2,523
3,029
2,850
-5,495
-4,290
-3,217
-4,678
Net Cash Before Disc. Operations and FX
-552
5,099
-2,760
-809
-153
1,363
-110
Change in Cash from Disc. Operations and Other
0
0
-69
13
0
0
0
Net Cash Before FX
-552
5,099
-2,829
-796
-153
1,363
-110
Effect of Foreign Exchange Rates
5
-2
2
-6
-6
-9
1
Net Changes in Cash
-547
5,096
-2,827
-802
-159
1,354
-109
Remarks
restated on Feb 19, 2013 n/a
calculated values,
restated on Feb 20, 2014 n/a
calculated values,
restated on Feb 23, 2015 n/a
calculated values,
restated on Feb 16, 2016 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
restated on Feb 14, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo